ArticleTheranostics2025

iRGD-TRP-PK1-modified red blood cell membrane vesicles as a new chemotherapeutic drug delivery and targeting system in head and neck cancer.

Suwen Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.